XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.06

+0.3%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Webhead who wrote (3861)	9/23/1997 8:45:00 AM
From: opalapril	of 17367

>>Up to 24 patients<< in the CF study seems very low to me, suggesting a high degree of XOMA confidence or a low FDA need for verification. And doesn't this news come shortly after rumors on this thread of a meeting between XOMA and the FDA, speculated to be aimed at accelerating the introduction of life-saving drug applications to market? Additional hint may be found in this line from the company release: >>Antibiotic resistance is an important area of research for XOMA, and also for the U.S. Food and Drug Administration (FDA).<< I rather think there is more here than meets the eye. At a minimum it seems unlikely XOMA would embark on this study just weeks before the long awaited Neuprex results unless indications are very, very positive.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next